Accreditations

We have been recognized globally for our quality outcomes and consumer satisfaction. Smilax received the ‘Outstanding Exports Award’ in Bulk Drugs Category for three consecutive years by the Government of India.

Smilax Laboratories Limited, Unit-I, Hyderabad

  • Successful Inspection by PMDA in Feb 2024
  • Inspected by USFDA in Apr 2015; EIR received
  • EU-GMP from OGYEI, Hungary in May 2020
  • WHO-GMP Certified by Drug Control Administration, Telangana State, India

Successful Inspection by PMDA in Feb 2024

Inspected by USFDA in Apr 2015; EIR received

EU-GMP from OGYEI, Hungary in May 2020

WHO-GMP Certified by Drug Control Administration, Telangana State, India

Smilax Laboratories Limited, Unit IV, Visakhapatnam

  • Facility inspected by JAZMP Slovenia in Jul 2011, Apr 2013 and Mar 2016
  • Inspected by PMDA, Japan in Feb 2023
  • Inspected by USFDA in Sep 2023; EIR received
  • WHO-GMP Certified by Drug Control Administration, Andhra Pradesh, India

Facility inspected by JAZMP Slovenia in Jul 2011, Apr 2013 and Mar 2016

Inspected by PMDA, Japan in Feb 2023

Inspected by USFDA in Sep 2023; EIR received

WHO-GMP Certified by Drug Control Administration, Andhra Pradesh, India

Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world.

Useful Links

Home
Corporate Profile
Our Strengths
Our Journey
Global Presence
APIs
API intermediates
Pellets and DC Granules
CDMO & CMO

Corporate Office

Smilax Laboratories Limited
12th Floor, Ramky Grandiose Towers Opp. Rolling Hills, Mind Space Road Janardhan Reddy Nagar, Gachibowli Hyderabad – 500 032, Telangana, India

Registered Office

Smilax Laboratories Limited
Plot No: 12/A, Phase – Ill, IDA, Jeedimetla, Hyderabad – 500 055, Telangana, India

© 2024 – All Rights Reserved